Baseline demographics and clinical characteristics (full analysis set)
| FlexibleMIB (n=115) | Conventional (n=108) | |
|---|---|---|
| Demographic/characteristic | [mean (SD)] | [mean (SD)] |
| Age (years) | 25.6 (5.1) | 25.3 (5.0) |
| Height (cm) | 167.6 (6.0) | 168.2 (6.5) |
| Weight (kg) | 63.1 (9.5) | 63.8 (9.1) |
| BMI (kg/m2) | 22.4 (2.9) | 22.5 (3.0) |
| Length of pretreatment screening period (days) | 79.6 (21.3) | 81.3 (25.5) |
| Number of days with dysmenorrhoeic pain before treatment (>140 days)* | 21.0 (7.3) | 22.0 (8.4) |
| Number of days with at least moderate dysmenorrhoeic pain before treatment (>140 days)* | 12.8 (5.7) | 13.8 (7.4) |
↵* Data were normalised to a 140-day period to allow comparisons with the 140-day treatment period. Pretreatment periods had a minimum length of 46 days. Data was cut after the first 140 days of the pretreatment period.
BMI, body mass index; MIB, management of (breakthrough) intracyclic bleeding; SD, standard deviation.